‘Losing Direction’: Allergan Investors Are Unhappy After A Wild 4 Hour Takeover Drama
The Business Insider posted on Fri 20 Apr 2018 Permalink Print
Allergan’s stock closed down 4% on Thursday, after the pharma giant said it was “in the early stages of considering a possible offer” for UK-listed Shire, only to say four hours later that it wouldn’t make an offer. The drama extends what’s been a tough year for the Botox-maker….Allergan’s stock dropped 8% after its initial interest and closed the day down 4%.
